Disc Medicine, Inc.
Financials
Valuation Metrics
Disc Medicine, Inc.'s Market Cap is $2.66B. At end of 2025 it was $2.80B. Ranked #1835 of 3,121 in US market (top 59%), #668 of 1,463 on NASDAQ (top 46%), #112 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 42%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $2.66B | US#1,835/3,121 Sec#112/266 |
| Revenue | $0.00 | US#2,889/3,121 Sec#196/266 |
| Net Income | $-246M | US—/3,121 Sec—/266 |
| Total Assets | $735M | US#2,608/3,121 Sec#127/266 |
| Net Assets | $644M | US#2,070/3,121 Sec#91/266 |
| Employees | 165 | US#2,528/3,121 Sec#138/266 |
| Value | ||
| P/B | 4.12x | US#2,044/3,121 Sec#119/266 |
| FCF Yield | -7.44% | US—/3,121 Sec—/266 |
| Profitability | ||
| ROE | -38.17% | US#2,616/3,121 Sec#130/266 |
| ROA | -33.45% | US#2,907/3,121 Sec#165/266 |
| Financial Health | ||
| Debt Ratio | 14.11% | US#163/3,121 Sec#67/266 |
| Total Debt | $61M | US#2,568/3,121 Sec#145/266 |
| FCF | $-198M | US#2,777/3,121 Sec#207/266 |
| Cash | $99M | US#2,237/3,121 Sec#177/266 |
| Current Ratio | 24.14x | US#102/3,121 Sec#17/266 |
| Performance | ||
| 1Y Return | 11.02% | US#1,368/3,121 Sec#166/266 |
| 1M Return | -13.43% | US#2,740/3,121 Sec#211/266 |
| From 52W High | -30.12% | US#2,094/3,121 Sec#163/266 |
| 1Y MDD | -40.55% | US#2,030/3,121 Sec#142/266 |
| Trading | ||
| Volume | 974,299 shares | US#1,836/3,121 Sec#192/266 |
| Trading Value | $67M | US#1,363/3,121 Sec#106/266 |
| Per Share | ||
| EPS | $-6.44 | US—/3,121 Sec—/266 |
| BPS | $16.86 | US#1,423/3,121 Sec#44/266 |
Company Info
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.